Amiperone

This classification denotes an antipsychotic agent with the molecular formula C24H28ClFN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FTX5V7543O, chemically known as 4-piperidinecarboxamide, 4-(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-n,n-dimethyl- (9ci) but generally known as amiperone, which bears US NIH Compound Identifier 71101. European Medicines Agency schedules Amiperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05452MIG. The term AMIPERONE is an International Non-Proprietary Name. AMIPERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amiperone under HS 29333999 and SITC 51574. As of Q4 2014, AMIPERONE remains the US FDA Preferred Term for this commodity. Amiperone bears US NLM identifiers UMLS ID C2346745 and NCI Concept Code C74172. SMILES: CLC1CCC(C2(CCN(CC2)CCCC(=O)C2CCC(F)CC2)C(=O)N(C)C)CC1.